Pay in 4 interest-free payments of $5.64 Learn more
Ships within 48 hours · Estimated delivery Jul 28 - Aug 2
Hepatology 37:14251434 McBean GJ (2002) Cerebral cystine uptake: a tale of two transporters
Preclinical Research Dosing Models Animal model studies have explored GHK-Cu at the following ranges: Topical (in vitro/ex vivo): 10100 M concentrations in cell culture media Subcutaneous (rodent models): 15 mg/kg body weight, administered 12x daily Wound healing models: Local application at 110 g/wound site Reconstitution for Research GHK-Cu is typically supplied as a lyophilized powder
The reduction by dutasteride of prostate cancer events (REDUCE) trial is another multicenter, randomized, international, placebocontrolled, double blind clinical trial initiated in 2003 to evaluate the ability of dutasteride to decrease the risk of biopsy detectable prostate cancer in men with moderately elevated PSA levels
Striatopallidal dysfunction underlies repetitive behavior in Shank3-deficient model of autism
US$ 26.81
US$ 24.11
US$ 25.61
US$ 21.23
US$ 24.24
US$ 29.44
US$ 28.37
US$ 25.86
US$ 28.90
US$ 29.55
US$ 22.63
US$ 25.20